Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges

Seminars in Cancer Biology(2022)10.1016/j.semcancer.2022.08.003Source: DataRank Database

STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges is a research paper published in Seminars in Cancer Biology (2022). On theSindex it has a DataRank of 0. It has been cited 111 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access111 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 9.67)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Sara G. Manore ORCID,Daniel Doheny ORCID,Hui‐Wen Lo ORCID,Grace L. Wong ORCID

Live enrichment

PubMed:35995341 PMC:PMC9714692 OpenAlex:https://openalex.org/W4293275146

National Institutes of Health

Grant: 1R01CA228137\u201301A1

National Institutes of Health

Grant: P30CA012197

National Institutes of Health

Grant: F31CA261027\u201301A1

DOD

Grant: W81XWH-19\u20131-0072

DOD

Grant: W81XWH-17\u20131-0044

DOD

Grant: W81XWH-20\u20131-0044

DOD

Grant: W81XWH-19\u20131-0753

NCI NIH HHS

Grant: F31 CA261027

NCI NIH HHS

Grant: R01 CA228137

FWCI

9.67

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9714692

publisherhttps://api.elsevier.com/content/article/PII:S1044579X22001833?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1044579X22001833?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.semcancer.2022.08.003

Fields of Study

Cytokine Signaling Pathways and InteractionsCancer-related Molecular PathwaysCancer Mechanisms and TherapyFemaleHumansBreast NeoplasmsNeoplasm Recurrence, LocalNeoplastic Stem CellsNeoplasms, Second PrimaryCarcinogenesis

MeSH Terms

Breast NeoplasmsFemaleHumansNeoplasm Recurrence, LocalNeoplastic Stem CellsNeoplasms, Second PrimaryCarcinogenesis

Keywords

Cancer researchSTAT2STAT3Breast cancerMetastasisSTAT4STAT6STAT5STAT proteinstatSTAT1BiologyTranscription factorCancer stem cellAngiogenesisCancerTransactivationImmunologyMedicineSignal transductionCell biologyGeneticsInterferonGeneSignal Transducer And Activator Of Transcription (Stat)Breast Cancer Stem Cells (Bcscs)Breast Cancer TherapeuticsStat Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being

STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges

FAIR Checklist

Authors (4)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)